228 related articles for article (PubMed ID: 9273301)
1. [Schizophrenia: receptors and clinical aspects].
Azorin JM
Encephale; 1997 Apr; 23 Spec No 2():17-9. PubMed ID: 9273301
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of schizophrenia: a review.
Sigmundson HK
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S70-5. PubMed ID: 7533053
[TBL] [Abstract][Full Text] [Related]
3. [Dopamine D2 and serotonin 5HT2 receptors: functions, interactions and clinical consequences in schizophrenia].
Guise S; Soubrouillard C; Blin O
Encephale; 1997 Apr; 23 Spec No 2():10-6. PubMed ID: 9273300
[TBL] [Abstract][Full Text] [Related]
4. Conventional versus novel antipsychotics: changing concepts and clinical implications.
Remington G; Chong SA
J Psychiatry Neurosci; 1999 Nov; 24(5):431-41. PubMed ID: 10586534
[TBL] [Abstract][Full Text] [Related]
5. Recent concepts in clinical psychiatry: drug treatment in schizophrenia.
Hussain SH
J Pak Med Assoc; 1991 Sep; 41(9):229-34. PubMed ID: 1683911
[No Abstract] [Full Text] [Related]
6. New perspectives on the clinical neurobiology of treatment response in schizophrenia.
Honer WG
Can J Psychiatry; 1994 Feb; 39(1):34-42. PubMed ID: 7910778
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
Wiesel FA
Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
[TBL] [Abstract][Full Text] [Related]
8. [Methodological constraints in evaluating anti-deficit effects].
Boyer P; Lecrubier Y; Rein W
Encephale; 1996 Jun; 22 Spec No 2():25-7. PubMed ID: 8767038
[TBL] [Abstract][Full Text] [Related]
9. The neurobiology of cognition in schizophrenia.
Tamminga CA
J Clin Psychiatry; 2006; 67 Suppl 9():9-13; discussion 36-42. PubMed ID: 16965183
[TBL] [Abstract][Full Text] [Related]
10. The neurochemical circuitry of schizophrenia.
Carlsson A
Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S10-4. PubMed ID: 16508890
[TBL] [Abstract][Full Text] [Related]
11. [Problems in evaluating new antipsychotic drugs].
Fleischhacker WW
Wien Med Wochenschr; 1998; 148(11-12):266-72. PubMed ID: 9746969
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of PCP, NMDA and opiate receptors.
Wilkins J
NIDA Res Monogr; 1989; 95():275-81. PubMed ID: 2577034
[No Abstract] [Full Text] [Related]
13. [Effect of neuroleptics on depressive symptoms].
Tabeze JP
Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
[No Abstract] [Full Text] [Related]
14. [Schizophrenia and neural transmission: an excess of analogical treatment?].
Tassin JP
Encephale; 1996 Oct; 22 Spec No 3():91-8. PubMed ID: 9036015
[No Abstract] [Full Text] [Related]
15. [Depressive symptoms in schizophrenia].
Gerard A
Encephale; 1998 Jul; 24 Spec No 1():24-6. PubMed ID: 9809250
[No Abstract] [Full Text] [Related]
16. [Psychopharmacologic approaches to schizophrenic psychoses].
Giacardy-Paty M; Soubrouillard C; Blin O
Encephale; 1995 Jun; 21 Spec No 3():3-8. PubMed ID: 7628339
[TBL] [Abstract][Full Text] [Related]
17. [Deficit schizophrenias].
Puech AJ
Encephale; 1996 Jun; 22 Spec No 2():1. PubMed ID: 8767033
[No Abstract] [Full Text] [Related]
18. New drugs for the treatment of schizophrenic patients.
Fleischhacker WW
Acta Psychiatr Scand Suppl; 1995; 388():24-30. PubMed ID: 7604735
[TBL] [Abstract][Full Text] [Related]
19. "Postpsychotic depression" and residual schizophrenia in a mental health hospital.
Mauri MC; Laini V; Barone R; Clemente A; Volonteri LS; Cerveri G; Steinhilber C; Fornier M
Encephale; 2000; 26(6):21-6. PubMed ID: 11217534
[TBL] [Abstract][Full Text] [Related]
20. "Awakening" from schizophrenia: intramolecular polypharmacy and the atypical antipsychotics.
Stahl SM
J Clin Psychiatry; 1997 Sep; 58(9):381-2. PubMed ID: 9378687
[No Abstract] [Full Text] [Related]
[Next] [New Search]
